1607future oncol (Future Medicine Ltd)
90
Structured Review
Future Medicine Ltd
1607future oncol
1607future Oncol, supplied by Future Medicine Ltd, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/1607future+oncol/1607future+oncol/pm28835114-5-0-10
Average 90 stars, based on 1 article reviews
1607future Oncol, supplied by Future Medicine Ltd, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/1607future+oncol/1607future+oncol/pm28835114-5-0-10
Average 90 stars, based on 1 article reviews
1607future oncol - by Bioz Stars,
2026-09
90/100 stars
Images
Related Articles
other:Article Title: Challenges faced when identifying patients for combination immunotherapy. Article Snippet: Department of Medicine, Roswell Park Cancer Institute, Buffalo, NY, USA Department of Medicine University of Buffalo Jacobs School of Medicine & Biomedical Sciences, Buffalo, NY, USA Departments of Hematology-Oncology, Cleveland Clinic Foundation, Cleveland, OH, USA Department of Immunology & Microbiology, Geisel School of Medicine, Lebanon, NH, USA Department of Medicine, Geisel School of Medicine, Lebanon, NH, USA Department of Pathology, Roswell Park Cancer Institute, Buffalo, NY, USA OmniSeq, Buffalo, NY, USA *Author for correspondence: marc.ernstoff@roswellpark.org In 1996, Jim Allison demonstrated that blocking the immune regulatory molecule CTLA-4 with anit-CTLA4 antibody led to enhance tumor responses in mice.. It would take an additional 15 years for human studies to confirm the potency and clinical efficacy of antiCTLA4, ultimately leading to US FDA approval of the first checkpoint inhibitor, ipilimumab.. Now with a plethora of immune-modulating agents demonstrating single agent safety and benefit across many tumor types, investigation on the optimal combination of immunebased therapies has begun in earnest. |